Oculis Holding AG (OCS) stock
OCSNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as OCSAW
$7.44+0.05 (+0.68%)
Close on Nov 19, 2026Market cap $447.07MP/E –Yield –
Oculis free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
For fiscal 2025 it was -CHF 66.61M. The highest annual figure on record is -CHF 12.05M in fiscal 2020.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -CHF 66.61M | – |
| FY2024 | Dec 31, 2024 | -CHF 49.15M | – |
| FY2023 | Dec 31, 2023 | -CHF 55.09M | – |
| FY2022 | Dec 31, 2022 | -CHF 25.14M | – |
| FY2021 | Dec 31, 2021 | -CHF 13.85M | – |
| FY2020 | Dec 31, 2020 | -CHF 12.05M | – |
See a number that looks wrong?